This document is page 103 of a financial report produced by Cowen on February 25, 2019. It displays 'Rating History' charts for three companies: GW Pharmaceuticals Plc, Tilray, and Turning Point Brands, showing stock prices versus target prices over time (2016-2019). The document is marked with the Bates stamp 'HOUSE_OVERSIGHT_024919' and notes it is intended for Michael Cella at Cowen.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address listed in the sidebar as the intended recipient of the report (michael.cella@cowen.com).
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Creator of the report (Cowen Collaborative Insights).
|
|
| BlueMatrix |
Provider of the charting technology used in the report.
|
|
| GW Pharmaceuticals Plc |
Subject of the first stock rating chart.
|
|
| Tilray |
Subject of the second stock rating chart.
|
|
| Turning Point Brands |
Subject of the third stock rating chart.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT'.
|
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
Complete text extracted from the document (1,334 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document